Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
6.59B
Market cap6.59B
Price-Earnings ratio
10.06
Price-Earnings ratio10.06
Dividend yield
Dividend yield
Average volume
296.70K
Average volume296.70K
High today
$264.30
High today$264.30
Low today
$244.05
Low today$244.05
Open price
$260.82
Open price$260.82
Volume
263.74K
Volume263.74K
52 Week high
$343.12
52 Week high$343.12
52 Week low
$211.43
52 Week low$211.43

Stock Snapshot

Bio-Rad Laboratories Class A(BIO) stock is priced at $244.21, giving the company a market capitalization of 6.59B. It carries a P/E multiple of 10.06.

During the trading session on 2026-05-01, Bio-Rad Laboratories Class A(BIO) shares reached a daily high of $264.30 and a low of $244.05. At a current price of $244.21, the stock is +0.1% higher than the low and still -7.6% under the high.

Trading activity shows a volume of 263.74K, compared to an average daily volume of 296.7K.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $343.12 and a low of $211.43.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $343.12 and a low of $211.43.

BIO News

TipRanks 17h
Bio-Rad Laboratories Reports Q1 2026 Results, Cuts Outlook

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 19h
Bio-Rad reports Q1 EPS $1.89, consensus $1.99

Reports Q1 revenue $592.1M, consensus $588.86M. Norman Schwartz, Bio-Rad’s (BIO) Chairman and CEO, stated: “Our first-quarter results reflected our resolve in n...

Analyst ratings

71%

of 7 ratings
Buy
28.6%
Hold
71.4%
Sell
0%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.